Skip to main content
Rural Health Information Hub

Advancing HIV Service Delivery Through Pharmacies and Pharmacists (R01 and R21 Clinical Trial Optional)

National Institute of Mental Health, National Institute on Minority Health and Health Disparities, National Institutes of Health
Letter of Intent (Optional): Jul 13, 2024
Application: Aug 13, 2024

A list of agency contacts by research area may be found in the application instructions.


This opportunity offers research funding designed to scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies. This includes the advancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services.

Specific areas of research interest include:

  • Research to advance pharmacy-based health screenings for HIV alongside screenings for multiple chronic illnesses and common comorbid conditions
  • Studies designed to create and scale models of pharmacy-based HIV PrEP delivery and adherence support
  • Research to improve access and use of HIV post-exposure prophylaxis (PEP) through pharmacies
  • Studies to expand the delivery and use of long-acting injectable PrEP and/or ART regimens though pharmacists and pharmacies
  • Studies that test pharmacy-based monitoring and support for antiretroviral treatment adherence
  • Research to advance prescription refill synchronization for HIV and other chronic conditions to improve medication adherence and health outcomes
  • Research to advance integrated services for HIV and other common comorbid conditions or chronic illnesses through pharmacies and pharmacists
  • Research that uses pharmacists and pharmacies as a vector for engaging youth, pregnant persons, or minoritized populations in HIV testing, prevention, or care
  • Research to advance programs that train pharmacists, pharmacy students, and pharmacy technicians and allied health professionals to support HIV prevention and care and address barriers such as stigma, bias, discrimination, or practice information gaps related to HIV and its comorbidities, as well as programs for continuing education and maintenance of knowledge and expertise in HIV prevention and care
  • Research in implementation strategies for pharmacist and pharmacy-delivered HIV services, including strategic collaborations with health ministries, health departments, medical centers, schools of pharmacy, Historically Black Colleges and Universities, Minority Serving Institutions, community-based and non-governmental organizations, or other partners
  • Studies to understand and address social and structural constraints and business needs of pharmacists' and pharmacy systems regarding HIV service delivery
  • Studies that model the impact and cost-effectiveness of pharmacy-delivered HIV services

Priority populations:

  • Racial and ethnic groups
  • Low socioeconomic status
  • Rural populations
  • Sexual and gender minority groups
  • People with disabilities

Eligible applicants include:

  • Higher education institutions
    • Public/state controlled institutions
    • Private institutions
  • Nonprofit organizations
    • With 501(c)(3) status
    • Without 501(c)(3) status
    • Native American tribal organizations
    • Faith-based or community-based organizations
    • Regional organizations
  • Governments
    • State
    • County
    • City or township
    • Special districts
    • Federally recognized Indian/Native American tribal governments
    • Indian/Native American tribal governments (other than federally recognized)
    • Eligible agencies of the federal government
    • U.S. territory or possession
  • Other
    • Independent school districts
    • Public housing authorities
    • Indian housing authorities
    • Non-domestic entities and non-domestic components of U.S. entities
    • Small businesses
    • For-profit organizations
Geographic coverage
Nationwide and U.S. Territories
Amount of funding

R21: The combined budget for direct costs for the 2 year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year.

R01: Project budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Application process

Links to the full announcement and online application procedures are available on

While not required, potential applicants are encouraged to email a letter of intent to by July 13, 2024.

Tagged as
HIV and AIDS ยท Research methods and resources

Organizations (3)

For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.